This is a copy of the June 9th edition of our weekly Newsletter, which we have been publishing since October 2015.
In late May, Governor Polis of Colorado signed legislation that will have important implications for the cannabis industry. In November, the law becomes effective that will enable public companies to own licenses in the state. The actual implementation won’t take place until early 2020, as the state still needs to issue final rules.
Colorado is a mature market with some leading brands, and many companies are generating not only large revenue but also profits. This will appeal to some multi-state operators (MSOs), especially those looking to be the biggest operators.
So far, the public company activity has been limited, which isn’t surprising given the lag to implementation, but we hear there are several MSOs beginning the due diligence process. It is likely that some of the companies will look to sell, but we wouldn’t be surprised to see some decide to go public themselves once able to do so.
This week, Medicine Man Technologies, which already had lined up the acquisition of related party Medicine Man, announced two pending transactions in the state, with the deals totaling $18 million in cash and stock. General Cannabis also announced a pending $2.1 million acquisition. iAnthus will now be able to recognize revenue from Organix in Breckenridge, and we expect MJardin will be able to purchase some of the companies for which it manages operations. SLANG Worldwide recently said it is likely to exercise its option to buy its partners in Colorado, and it seems reasonable to expect Dixie Brands to do so as well.
It will be quite interesting to see which MSOs pursue Colorado aggressively, as the dynamics of this mature market are quite different than the highly regulated and limited license states in the East or even California, which has a lot of runway due to the recent regulatory implementation there. Revenue and profits in the near term could be valuable, and there are some branding opportunities as well, but the growth of the market is very limited. We will be watching the multiples to sales on any transactions and listening to the deal rationales, as cost savings associated with consolidation are likely going to drive the financial results.
To learn more about Medicine Man Technologies, a client of New Cannabis Ventures, visit the company’s Investor Dashboard that we maintain on its behalf and click the blue Follow Company button in order to stay up to date with their progress.
New Cannabis Ventures publishes curated articles as well as exclusive news. Here is some of the most interesting business content from this week:
- Aleafia Health Announces $35 Million Public Offering of 8.5% Convertible Debenture Units
- Exclusive: American Cannabis Stocks Drop 13.1% in May
- Exclusive: Cannabis Stocks Retreat in May
- Cresco Capital Partners Raises $60M in Oversubscribed Cannabis Private Equity Fund
- DionyMed Brands Lawsuit Alleges Eaze Defrauds Credit Card Companies
- Elixinol Global Sells 12.8 Million Shares at A$3.90 to Fund CBD Growth
- Fire & Flower to Issue $15 Million in Convertible Notes
- Exclusive: Large LPs Lead Canadian Cannabis Producers Lower in May
- Medicine Man Technologies Lines Up Two Colorado Cannabis Acquisitions
- PharmaCielo to Acquire International Cannabis Company Creso Pharma for A$122 Million
- Exclusive: Top 40 Revenue Generating Cannabis Stocks Ranked as of May 31st
- Exclusive: Vinzan International is Using Agricultural Best Practices to Build a Global Cannabis Business
To get real-time updates download our free mobile app for Android or Apple devices, like our Facebook page, or follow Alan on Twitter. Share and discover industry news with like-minded people on the largest cannabis investor and entrepreneur group on LinkedIn.
Use the suite of professionally managed NCV Cannabis Stock Indices to monitor the performance of publicly-traded cannabis companies within the day or over longer time-frames. In addition to the comprehensive Global Cannabis Stock Index, we offer a family of indices to track Canadian licensed producers as well as the American Cannabis Operator Index.
View the Public Cannabis Company Revenue Tracker, which ranks the top revenue producing cannabis stocks that generate industry sales of more than $5 million per quarter.
Discover upcoming new listings with the curated Cannabis Stock IPOs and New Issues Tracker.
Stay on top of some of the most important communications from public companies by viewing upcoming cannabis investor earnings conference calls.
Consider subscribing to 420 Investor, Alan’s comprehensive stock due diligence platform since 2013 for more in-depth information and market intelligence about the publicly traded cannabis sector.
Find your place in the cannabis industry by visiting our Careers and Jobs Page and learn which companies are hiring aggressively.
Alan & Joel